Lovastatin inhibits low-density lipoprotein oxidation and alters its fluidity and uptake by macrophages: In vitro and in vivo studies
- 31 March 1992
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 41 (3), 229-235
- https://doi.org/10.1016/0026-0495(92)90263-a
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Dual Effect of Lovastatin and Simvastatin on LDL-Macrophage Interactioncclm, 1991
- Malondialdehyde affects the physico-chemical and biological characteristics of oxidized low density lipoproteinAtherosclerosis, 1990
- Platelet secretory products increase low density lipoprotein oxidation, enhance its uptake by macrophages, and reduce its fluidity.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990
- Effect of probucol on the physical properties of low-density lipoproteins oxidized by copperBiochemistry, 1989
- Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1988
- Studies on the mechanism of action of probucolThe American Journal of Cardiology, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patientsBiochemical Medicine, 1983
- Effects of fat level, feeding period, and source of fat on lipid fluidity and physical state of rabbit plasma lipoproteinsAtherosclerosis, 1983
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972